These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 9785003)

  • 1. Pathogenesis of autosomal dominant polycystic kidney disease: role of apoptosis.
    Zhou XJ; Kukes G
    Diagn Mol Pathol; 1998 Apr; 7(2):65-8. PubMed ID: 9785003
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The pathogenesis of polycystic kidney disease.
    Carone FA; Bacallao R; Kanwar YS
    Histol Histopathol; 1995 Jan; 10(1):213-21. PubMed ID: 7756739
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Berberine slows cell growth in autosomal dominant polycystic kidney disease cells.
    Bonon A; Mangolini A; Pinton P; Del Senno L; Aguiari G
    Biochem Biophys Res Commun; 2013 Nov; 441(3):668-74. PubMed ID: 24184483
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pkd1 regulates immortalized proliferation of renal tubular epithelial cells through p53 induction and JNK activation.
    Nishio S; Hatano M; Nagata M; Horie S; Koike T; Tokuhisa T; Mochizuki T
    J Clin Invest; 2005 Apr; 115(4):910-8. PubMed ID: 15761494
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mcp1 Promotes Macrophage-Dependent Cyst Expansion in Autosomal Dominant Polycystic Kidney Disease.
    Cassini MF; Kakade VR; Kurtz E; Sulkowski P; Glazer P; Torres R; Somlo S; Cantley LG
    J Am Soc Nephrol; 2018 Oct; 29(10):2471-2481. PubMed ID: 30209078
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Integrin-Linked Kinase Signaling Promotes Cyst Growth and Fibrosis in Polycystic Kidney Disease.
    Raman A; Reif GA; Dai Y; Khanna A; Li X; Astleford L; Parnell SC; Calvet JP; Wallace DP
    J Am Soc Nephrol; 2017 Sep; 28(9):2708-2719. PubMed ID: 28522687
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cell Proliferation and Apoptosis in ADPKD.
    Lee EJ
    Adv Exp Med Biol; 2016; 933():25-34. PubMed ID: 27730432
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Polycystic kidney disease: huge kidneys, huge problems, huge progress.
    Grantham JJ
    Trans Am Clin Climatol Assoc; 1997; 108():165-70; discussion 170-2. PubMed ID: 9108675
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Apoptosis and loss of renal tissue in polycystic kidney diseases.
    Woo D
    N Engl J Med; 1995 Jul; 333(1):18-25. PubMed ID: 7776989
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Autosomal dominant polycystic kidney disease: recent advances in pathogenesis and treatment.
    Chang MY; Ong AC
    Nephron Physiol; 2008; 108(1):p1-7. PubMed ID: 18075279
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The hallmarks of cancer: relevance to the pathogenesis of polycystic kidney disease.
    Seeger-Nukpezah T; Geynisman DM; Nikonova AS; Benzing T; Golemis EA
    Nat Rev Nephrol; 2015 Sep; 11(9):515-34. PubMed ID: 25870008
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of specific genes activating RAGE on polycystic kidney disease.
    Park EY; Seo MJ; Park JH
    Am J Nephrol; 2010; 32(2):169-78. PubMed ID: 20606421
    [TBL] [Abstract][Full Text] [Related]  

  • 13. C-myc-induced apoptosis in polycystic kidney disease is Bcl-2 and p53 independent.
    Trudel M; Lanoix J; Barisoni L; Blouin MJ; Desforges M; L'Italien C; D'Agati V
    J Exp Med; 1997 Dec; 186(11):1873-84. PubMed ID: 9382886
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Regulation of ciliary trafficking of polycystin-2 and the pathogenesis of autosomal dominant polycystic kidney disease.
    Cai Y; Tang Z
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2010 Feb; 35(2):93-9. PubMed ID: 20197605
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MicroRNA-21 Aggravates Cyst Growth in a Model of Polycystic Kidney Disease.
    Lakhia R; Hajarnis S; Williams D; Aboudehen K; Yheskel M; Xing C; Hatley ME; Torres VE; Wallace DP; Patel V
    J Am Soc Nephrol; 2016 Aug; 27(8):2319-30. PubMed ID: 26677864
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Altered Hippo signalling in polycystic kidney disease.
    Happé H; van der Wal AM; Leonhard WN; Kunnen SJ; Breuning MH; de Heer E; Peters DJ
    J Pathol; 2011 May; 224(1):133-42. PubMed ID: 21381034
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dysregulation of cellular proliferation and apoptosis mediates human autosomal dominant polycystic kidney disease (ADPKD).
    Lanoix J; D'Agati V; Szabolcs M; Trudel M
    Oncogene; 1996 Sep; 13(6):1153-60. PubMed ID: 8808689
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Polycystic kidney disease: etiology, pathogenesis, and treatment.
    Martinez JR; Grantham JJ
    Dis Mon; 1995 Nov; 41(11):693-765. PubMed ID: 7587886
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of keratinocyte growth factor in the pathogenesis of autosomal dominant polycystic kidney disease.
    Mei C; Mao Z; Shen X; Wang W; Dai B; Tang B; Wu Y; Cao Y; Zhang S; Zhao H; Sun T
    Nephrol Dial Transplant; 2005 Nov; 20(11):2368-75. PubMed ID: 16141466
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recent Trends in ADPKD Research.
    Shin YB; Park JH
    Adv Exp Med Biol; 2016; 933():3-11. PubMed ID: 27730430
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.